Any t/o offer from BP won't come in at the current market price, it will come in at the bidder's valuation based on a variety of metrics and competitive pressure and it is then up to the NEU board to recommend it to shareholders or not based on their valuation. Considering the commercial potential of 2591 and looking at comparable industry transactions over the last couple of years, I can't see a valuation below AUD$5 bn being seriously entertained which is still double today's SP.
This is also one the reasons why talk of shorting this company amuses me - can you imagine being caught short when a t/o offer for at least twice the current SP comes in?!
- Forums
- ASX - By Stock
- M&A
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.06%
!
$13.12

Any t/o offer from BP won't come in at the current market price,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.12 |
Change
0.265(2.06%) |
Mkt cap ! $1.635B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.744M | 361.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 143 | $13.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.12 | 243 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12 | 13.140 |
7 | 129 | 13.130 |
9 | 742 | 13.120 |
12 | 1779 | 13.110 |
5 | 1322 | 13.100 |
Price($) | Vol. | No. |
---|---|---|
13.150 | 231 | 1 |
13.160 | 803 | 6 |
13.170 | 1154 | 7 |
13.180 | 6765 | 13 |
13.190 | 2485 | 10 |
Last trade - 13.05pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online